BLEECKER (BLEE.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:BLEE - FR0000062150 - Common Stock
105 EUR
-4 (-3.67%)
Taking everything into account, BLEE scores 2 out of 10 in our fundamental rating. BLEE was compared to 40 industry peers in the Diversified REITs industry. Both the profitability and financial health of BLEE have multiple concerns. BLEE has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BLEE has reported negative net income.
In the past year BLEE had a positive cash flow from operations.
In multiple years BLEE reported negative net income over the last 5 years.
Each year in the past 5 years BLEE had a positive operating cash flow.
1.2 Ratios
BLEE has a worse Return On Assets (-4.01%) than 87.80% of its industry peers.
Looking at the Return On Equity, with a value of -9.19%, BLEE is doing worse than 87.80% of the companies in the same industry.
BLEE's Return On Invested Capital of 1.37% is on the low side compared to the rest of the industry. BLEE is outperformed by 82.93% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BLEE is below the industry average of 3.53%.
The last Return On Invested Capital (1.37%) for BLEE is above the 3 year average (0.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.01% | ||
| ROE | -9.19% | ||
| ROIC | 1.37% |
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
1.3 Margins
BLEE's Operating Margin of 38.96% is on the low side compared to the rest of the industry. BLEE is outperformed by 78.05% of its industry peers.
BLEE's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 48.62%, BLEE is doing worse than 73.17% of the companies in the same industry.
In the last couple of years the Gross Margin of BLEE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.96% | ||
| PM (TTM) | N/A | ||
| GM | 48.62% |
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLEE is destroying value.
The number of shares outstanding for BLEE remains at a similar level compared to 1 year ago.
BLEE has about the same amout of shares outstanding than it did 5 years ago.
BLEE has a better debt/assets ratio than last year.
2.2 Solvency
BLEE has an Altman-Z score of 0.87. This is a bad value and indicates that BLEE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.87, BLEE perfoms like the industry average, outperforming 58.54% of the companies in the same industry.
The Debt to FCF ratio of BLEE is 134.93, which is on the high side as it means it would take BLEE, 134.93 years of fcf income to pay off all of its debts.
BLEE has a worse Debt to FCF ratio (134.93) than 82.93% of its industry peers.
A Debt/Equity ratio of 1.16 is on the high side and indicates that BLEE has dependencies on debt financing.
With a Debt to Equity ratio value of 1.16, BLEE is not doing good in the industry: 80.49% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | 134.93 | ||
| Altman-Z | 0.87 |
ROIC/WACC0.33
WACC4.14%
2.3 Liquidity
A Current Ratio of 0.93 indicates that BLEE may have some problems paying its short term obligations.
BLEE has a better Current ratio (0.93) than 78.05% of its industry peers.
A Quick Ratio of 0.93 indicates that BLEE may have some problems paying its short term obligations.
BLEE's Quick ratio of 0.93 is amongst the best of the industry. BLEE outperforms 82.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 37.63% over the past year.
BLEE shows a decrease in Revenue. In the last year, the revenue decreased by -9.71%.
Measured over the past years, BLEE shows a small growth in Revenue. The Revenue has been growing by 7.33% on average per year.
EPS 1Y (TTM)37.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.07%
Revenue 1Y (TTM)-9.71%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%-20.78%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
BLEE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, BLEE is valued expensively inside the industry as 80.49% of the companies are valued cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.81 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for BLEE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:BLEE (12/16/2025, 7:00:00 PM)
105
-4 (-3.67%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners71.74%
Ins Owner ChangeN/A
Market Cap118.65M
Revenue(TTM)26.78M
Net Income(TTM)-23.62M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.43 | ||
| P/FCF | 51.81 | ||
| P/OCF | 12.74 | ||
| P/B | 0.46 | ||
| P/tB | 0.47 | ||
| EV/EBITDA | N/A |
EPS(TTM)-21.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.03
FCFY1.93%
OCF(TTM)8.24
OCFY7.85%
SpS23.7
BVpS226.55
TBVpS223.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.01% | ||
| ROE | -9.19% | ||
| ROCE | 1.86% | ||
| ROIC | 1.37% | ||
| ROICexc | 1.37% | ||
| ROICexgc | 1.37% | ||
| OM | 38.96% | ||
| PM (TTM) | N/A | ||
| GM | 48.62% | ||
| FCFM | 8.55% |
ROA(3y)-3.74%
ROA(5y)0.76%
ROE(3y)-8.73%
ROE(5y)0.96%
ROIC(3y)0.99%
ROIC(5y)0.83%
ROICexc(3y)0.99%
ROICexc(5y)0.84%
ROICexgc(3y)1%
ROICexgc(5y)0.84%
ROCE(3y)1.34%
ROCE(5y)1.13%
ROICexgc growth 3Y47.05%
ROICexgc growth 5Y20.23%
ROICexc growth 3Y47.05%
ROICexc growth 5Y20.22%
OM growth 3Y30.72%
OM growth 5Y9.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.22%
GM growth 5Y5.35%
F-Score5
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | 134.93 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 26.22% | ||
| Interest Coverage | 0.58 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | 0.87 |
F-Score5
WACC4.14%
ROIC/WACC0.33
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)23.61%
Cap/Sales(5y)36.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.71%
Revenue growth 3Y11.64%
Revenue growth 5Y7.33%
Sales Q2Q%-20.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.04%
EBIT growth 3Y45.94%
EBIT growth 5Y17.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1661.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y189.13%
OCF growth 3Y120.67%
OCF growth 5Y3.92%
BLEECKER / BLEE.PA FAQ
Can you provide the ChartMill fundamental rating for BLEECKER?
ChartMill assigns a fundamental rating of 2 / 10 to BLEE.PA.
What is the valuation status of BLEECKER (BLEE.PA) stock?
ChartMill assigns a valuation rating of 0 / 10 to BLEECKER (BLEE.PA). This can be considered as Overvalued.
Can you provide the profitability details for BLEECKER?
BLEECKER (BLEE.PA) has a profitability rating of 3 / 10.
Can you provide the financial health for BLEE stock?
The financial health rating of BLEECKER (BLEE.PA) is 2 / 10.